Eléments de l'association

	Ego Seeman	16
	Ostéoporose	47
	Ego Seeman *Sauf* Ostéoporose"	7
	Ostéoporose *Sauf* Ego Seeman"	38
	Ego Seeman Et Ostéoporose	9
	Ego Seeman Ou Ostéoporose	54
	*Corpus*	11069

List of bibliographic references

Number of relevant bibliographic references: 9.

Ident.	Authors (with country if any)	Title
002401	Ego Seeman [Australie] ; Steven Boonen [Belgique] ; Frederik Borgström [Suède] ; Bruno Vellas [France] ; Jean-Pierre Aquino [France] ; Jutta Semler [Allemagne] ; Claude-Laurent Benhamou [France] ; Jean-Marc Kaufman [Belgique] ; Jean-Yves Reginster [Belgique]	Five years treatment with strontium ranelate reduces vertebral and nonvertebral fractures and increases the number and quality of remaining life-years in women over 80 years of age
003285	Paul D. Miller [États-Unis] ; Pierre D. Delmas [France] ; Robert Lindsay [États-Unis] ; Nelson B. Watts [États-Unis] ; Marjorie Luckey [États-Unis] ; Jonathan Adachi [Canada] ; Kenneth Saag [États-Unis] ; Susan L. Greenspan [États-Unis] ; Ego Seeman [Australie] ; Steven Boonen [Belgique] ; Suzanne Meeves [États-Unis] ; Thomas F. Lang [États-Unis] ; John P. Bilezikian [États-Unis]	Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate
003C15	YUNBO DUAN [Australie] ; Francois Duboeuf [France] ; Francoise Munoz [France] ; Pierre D. Delmas [France] ; Ego Seeman [Australie]	The fracture risk index and bone mineral density as predictors of vertebral structural failure
004200	Ego Seeman [Australie] ; Gerald G. Crans [États-Unis] ; Adolfo Diez-Perez [Espagne] ; Karen V. Pinette [États-Unis] ; Pierre D. Delmas [France]	Anti-vertebral fracture efficacy of raloxifene : a meta-analysis
004316	John A. Kanis [Royaume-Uni] ; Ego Seeman [Australie] ; Olof Johnell [Suède] ; Rene Rizzoli [Suisse] ; Pierre Delmas [France]	The perspective of the International Osteoporosis Foundation on the official positions of the International Society for Clinical densitometry
004894	Pierre J. Meunier [France] ; Christian Roux [France] ; Ego Seeman [Australie] ; Sergio Ortolani [Italie] ; Janusz E. Badurski [Pologne] ; Tim D. Spector [Royaume-Uni] ; Jorge Cannata [Espagne] ; Adam Balogh [Hongrie] ; Ernst-Martin Lemmel [Allemagne] ; Stig Pors-Nielsen [Belgique] ; René Rizzoli [Suisse] ; Harry K. Genant [États-Unis] ; Jean-Yves Reginster [Belgique]	The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis
004E31	Ego Seeman [Australie]	Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis
005618	Jonathan D. Adachi [Canada] ; Kenneth G. Saag [États-Unis] ; Pierre D. Delmas [France] ; Uri A. Liberman [Israël] ; Ronald D. Emkey [États-Unis] ; Ego Seeman [Australie] ; Nancy E. Lane [États-Unis] ; Jean-Marc Kaufman [Belgique] ; Patrice E. E. Poubelle [Canada] ; Federico Hawkins ; Ricardo Correa-Rotter ; Charles-Joel Menkes ; Jose A. Rodriguez-Portales ; Thomas J. Schnitzer ; Joel A. Block ; Jeffrey Wing ; Harris H. Mcilwain ; Rene Westhovens ; Jacques Brown [Canada] ; Jose A. Melo-Gomes ; Barry L. Gruber ; Melissa J. Yanover ; Maria Odette R. Leite ; Kerry G. Siminoski ; Michael C. Nevitt ; John T. Sharp ; Marie-Pierre Malice ; Thomas Dumortier ; Michelle Czachur ; Wendy Carofano ; Anastasia Daifotis	Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. A randomized, double-blind, placebo-controlled extension trial
005714	Robert Lindsay [États-Unis] ; Stuart L. Silverman [États-Unis] ; Cyrus Cooper [Royaume-Uni] ; David A. Hanley [Canada] ; Ian Barton [Royaume-Uni] ; Susan B. Broy [États-Unis] ; Angelo Licata [États-Unis] ; Laurent Benhamou [France] ; Piet Geusens [Belgique, Pays-Bas] ; Kirsten Flowers [États-Unis] ; Hilmar Stracke [Allemagne] ; Ego Seeman [Australie]	Risk of new vertebral fracture in the year following a fracture

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024